Laird Superfood Reports Fourth Quarter & FY2021 Financial Results
Laird Superfood (NYSE American: LSF) reported a 43% increase in net sales for FY2021, totaling $36.8 million. Online sales made up 62% of total revenue, while direct-to-consumer sales surged 87%. Despite increased net sales, the company recorded a net loss of $23.9 million or $2.66 per diluted share, worsening from the previous year's loss of $14.5 million. Operating expenses rose significantly to $33.4 million, influenced by heightened marketing and administrative costs. For 2022, Laird anticipates net sales between $41 million to $44 million.
- Net sales increased 43% year-over-year to $36.8 million for FY2021.
- Online sales contributed 62% of total net sales, with direct-to-consumer sales up 87%.
- Gross profit rose 43% to $9.4 million, maintaining a gross margin of 25.6%.
- Net loss increased to $23.9 million, or $2.66 per diluted share, from a loss of $14.5 million last year.
- Operating expenses surged to $33.4 million, up from $19.5 million the previous year.
FY2021 Net Sales Increased
Online Sales Contribute
Fourth Quarter 2021 Highlights
-
Net Sales increased29% year over year to .$9.4 million
-
Online contributed
66% ofNet Sales , increasing39% year over year with direct-to-consumer up49% .
-
Wholesale contributed
33% ofNet Sales , increasing16% year over year, driven by continued expansion in grocery from both liquid creamer and shelf stable products.
-
Gross Profit was
and gross margin was$2.2 million 23.6% compared to Gross Profit of and gross margin of$1.5 million 20.1% in the prior year period.
-
Net loss attributable to common stockholders was
, or$6.9 million per diluted share, compared to a net loss of$0.76 , or$4.5 million per diluted share, in the prior year period.$0.51
“Fourth quarter results were in line with the revised expectations that we shared with you at the end of January. Our
For the Three Months Ended
Three Months Ended |
||||||||||||||
2021 |
|
2020 |
||||||||||||
$ |
|
% of Total |
|
$ |
|
% of Total |
||||||||
Coffee creamers | $ |
5,177,126 |
|
55 |
% |
$ |
5,146,268 |
|
71 |
% |
||||
Hydration and beverage enhancing supplements |
|
1,290,336 |
|
14 |
% |
|
1,015,709 |
|
14 |
% |
||||
Harvest snacks and other food items |
|
1,821,220 |
|
19 |
% |
|
135,509 |
|
2 |
% |
||||
Coffee, tea, and hot chocolate products |
|
1,874,473 |
|
20 |
% |
|
1,805,126 |
|
25 |
% |
||||
Other |
|
438,459 |
|
5 |
% |
|
195,655 |
|
3 |
% |
||||
Gross sales |
|
10,601,614 |
|
113 |
% |
|
8,298,267 |
|
114 |
% |
||||
Shipping income |
|
196,384 |
|
2 |
% |
|
27,783 |
|
0 |
% |
||||
Returns and discounts |
|
(1,430,439 |
) |
(15 |
)% |
|
(1,041,321 |
) |
(14 |
)% |
||||
Sales, net | $ |
9,367,559 |
|
100 |
% |
$ |
7,284,729 |
|
100 |
% |
||||
Online |
|
6,195,224 |
|
66 |
% |
|
4,452,667 |
|
61 |
% |
||||
Wholesale |
|
3,069,198 |
|
33 |
% |
|
2,655,690 |
|
36 |
% |
||||
Food service |
|
103,137 |
|
1 |
% |
|
176,372 |
|
2 |
% |
||||
Sales, net | $ |
9,367,559 |
|
100 |
% |
$ |
7,284,729 |
|
100 |
% |
Gross Profit was
Operating expenses were
Loss from operations was
Net loss was
For the Year Ended
Years Ended |
||||||||||||||
2021 |
|
2020 |
||||||||||||
$ |
|
% of Total |
|
$ |
|
% of Total |
||||||||
Coffee creamers | $ |
21,767,409 |
|
59 |
% |
$ |
18,432,236 |
|
71 |
% |
||||
Hydration and beverage enhancing supplements |
|
5,814,629 |
|
16 |
% |
|
3,893,406 |
|
15 |
% |
||||
Harvest snacks and other food items |
|
5,228,888 |
|
14 |
% |
|
135,509 |
|
1 |
% |
||||
Coffee, tea, and hot chocolate products |
|
7,108,361 |
|
19 |
% |
|
5,922,017 |
|
23 |
% |
||||
Other |
|
808,352 |
|
2 |
% |
|
588,754 |
|
2 |
% |
||||
Gross sales |
|
40,727,639 |
|
110 |
% |
|
28,971,922 |
|
112 |
% |
||||
Shipping income |
|
457,879 |
|
1 |
% |
|
248,865 |
|
1 |
% |
||||
Returns and discounts |
|
(4,374,565 |
) |
(11 |
)% |
|
(3,437,561 |
) |
(13 |
)% |
||||
Sales, net | $ |
36,810,953 |
|
100 |
% |
$ |
25,783,226 |
|
100 |
% |
||||
Online |
|
22,687,736 |
|
62 |
% |
|
14,501,706 |
|
56 |
% |
||||
Wholesale |
|
13,598,792 |
|
37 |
% |
|
10,773,345 |
|
42 |
% |
||||
Food service |
|
524,425 |
|
1 |
% |
|
508,175 |
|
2 |
% |
||||
Sales, net | $ |
36,810,953 |
|
100 |
% |
$ |
25,783,226 |
|
100 |
% |
Gross Profit was
Operating expenses were
Loss from operations was
Net loss attributable to common stockholders was
Balance Sheet and Cash Flow Highlights
The Company had
Capital expenditures totaled
2022 Outlook
We estimate
Conference Call and Webcast Details
The Company will host a conference call and webcast at
About
Forward-Looking Statements
This press release and the conference call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Laird Superfood’s future financial performance and growth. These forward-looking statements are based on Laird Superfood’s current assumptions, expectations and beliefs and are subject to substantial risks, uncertainties, assumptions and changes in circumstances that may cause Laird Superfood’s actual results, performance or achievements to differ materially from those expressed or implied in any forward-looking statement. We expressly disclaim any obligation to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
The risks and uncertainties referred to above include, but are not limited to: (1) the effects of the current COVID-19 pandemic, or of other global outbreaks of pandemics or contagious diseases or fear of such outbreaks, including on our supply chain, the demand for our products, and on overall economic conditions and consumer confidence and spending levels; (2) volatility regarding our revenue, expenses, including shipping expenses, and other operating results; (3) our ability to acquire new direct and wholesale customers and successfully retain existing customers; (4) our ability to attract and retain our suppliers, distributors and co-manufacturers, and effectively manage their costs and performance; (5) effects of real or perceived quality or health issues with our products or other issues that adversely affect our brand and reputation; (6) our ability to innovate on a timely and cost-effective basis, predict changes in consumer preferences and develop successful new products, or updates to existing products, and develop innovative marketing strategies; (7) adverse developments regarding prices and availability of raw materials and other inputs, a substantial amount of which come from a limited number of suppliers outside
STATEMENTS OF OPERATIONS | ||||||||
For the Three Months Ended
|
||||||||
2021 |
|
2020 |
||||||
Sales, net | $ |
9,367,559 |
|
$ |
7,284,729 |
|
||
Cost of goods sold |
|
(7,153,814 |
) |
|
(5,819,762 |
) |
||
Gross profit |
|
2,213,745 |
|
|
1,464,967 |
|
||
General and administrative | ||||||||
Salaries, wages and benefits |
|
1,289,719 |
|
|
886,214 |
|
||
Stock-based compensation |
|
803,345 |
|
|
835,203 |
|
||
Professional fees |
|
727,733 |
|
|
316,368 |
|
||
Insurance expense |
|
579,813 |
|
|
519,848 |
|
||
Office expense |
|
350,592 |
|
|
217,715 |
|
||
Occupancy |
|
116,115 |
|
|
100,606 |
|
||
Merchant service fees |
|
169,350 |
|
|
127,437 |
|
||
Other expense |
|
362,163 |
|
|
174,056 |
|
||
Total general and administrative expenses |
|
4,398,830 |
|
|
3,177,447 |
|
||
Research and product development | ||||||||
Salaries, wages and benefits |
|
116,868 |
|
|
70,318 |
|
||
Stock-based compensation |
|
6,745 |
|
|
3,567 |
|
||
Product development expense |
|
46,485 |
|
|
67,769 |
|
||
Other expense |
|
1,886 |
|
|
2,526 |
|
||
Total research and product development expenses |
|
171,984 |
|
|
144,180 |
|
||
Sales and marketing | ||||||||
Salaries, wages and benefits |
|
675,211 |
|
|
611,868 |
|
||
Stock-based compensation |
|
66,432 |
|
|
30,570 |
|
||
Advertising |
|
2,256,998 |
|
|
1,111,371 |
|
||
General marketing |
|
1,412,265 |
|
|
684,972 |
|
||
Other expense |
|
250,229 |
|
|
211,578 |
|
||
Total sales and marketing expenses |
|
4,661,135 |
|
|
2,650,359 |
|
||
Total expenses |
|
9,231,949 |
|
|
5,971,986 |
|
||
Operating loss |
|
(7,018,204 |
) |
|
(4,507,019 |
) |
||
Other income (expense) | ||||||||
Interest and dividend income |
|
12,458 |
|
|
13,423 |
|
||
Gain on sale of available-for-sale securities |
|
— |
|
|
— |
|
||
Grant income |
|
51,000 |
|
|
— |
|
||
Total other income |
|
63,458 |
|
|
13,423 |
|
||
Loss before income taxes |
|
(6,954,746 |
) |
|
(4,493,596 |
) |
||
Income tax expense |
|
68,661 |
|
|
— |
|
||
Net loss | $ |
(6,886,085 |
) |
$ |
(4,493,596 |
) |
||
Net loss per share attributable to |
||||||||
Basic | $ |
(0.76 |
) |
$ |
(0.51 |
) |
||
Diluted | $ |
(0.76 |
) |
$ |
(0.51 |
) |
||
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, basic and diluted |
|
9,067,235 |
|
|
8,876,431 |
|
STATEMENTS OF OPERATIONS | ||||||||
For the Years Ended
|
||||||||
2021 |
|
2020 |
||||||
Sales, net | $ |
36,810,953 |
|
$ |
25,783,226 |
|
||
Cost of goods sold |
|
(27,379,082 |
) |
|
(19,204,642 |
) |
||
Gross profit |
|
9,431,871 |
|
|
6,578,584 |
|
||
General and administrative | ||||||||
Salaries, wages and benefits |
|
4,822,910 |
|
|
3,546,489 |
|
||
Stock-based compensation |
|
3,569,416 |
|
|
1,424,803 |
|
||
Professional fees |
|
2,232,171 |
|
|
963,791 |
|
||
Insurance expense |
|
2,140,208 |
|
|
666,045 |
|
||
Office expense |
|
1,217,651 |
|
|
735,669 |
|
||
Occupancy |
|
430,148 |
|
|
612,998 |
|
||
Merchant service fees |
|
598,657 |
|
|
375,792 |
|
||
Other expense |
|
1,448,101 |
|
|
502,692 |
|
||
Total general and administrative expenses |
|
16,459,262 |
|
|
8,828,279 |
|
||
Research and product development | ||||||||
Salaries, wages and benefits |
|
421,521 |
|
|
272,605 |
|
||
Stock-based compensation |
|
23,561 |
|
|
10,261 |
|
||
Product development expense |
|
566,695 |
|
|
209,275 |
|
||
Other expense |
|
18,350 |
|
|
16,029 |
|
||
Total research and product development expenses |
|
1,030,127 |
|
|
508,170 |
|
||
Sales and marketing | ||||||||
Salaries, wages and benefits |
|
2,529,231 |
|
|
2,669,384 |
|
||
Stock-based compensation |
|
228,968 |
|
|
661,026 |
|
||
Advertising |
|
7,570,879 |
|
|
4,257,963 |
|
||
General marketing |
|
4,491,446 |
|
|
1,568,258 |
|
||
Other expense |
|
1,074,374 |
|
|
1,014,675 |
|
||
Total sales and marketing expenses |
|
15,894,898 |
|
|
10,171,306 |
|
||
Total expenses |
|
33,384,287 |
|
|
19,507,755 |
|
||
Operating loss |
|
(23,952,416 |
) |
|
(12,929,171 |
) |
||
Other income (expense) | ||||||||
Interest and dividend income |
|
48,704 |
|
|
64,943 |
|
||
Gain on sale of available-for-sale securities |
|
— |
|
|
13,927 |
|
||
Grant income |
|
51,000 |
|
|
— |
|
||
Total other income |
|
99,704 |
|
|
78,870 |
|
||
Loss before income taxes |
|
(23,852,712 |
) |
|
(12,850,301 |
) |
||
Income tax expense |
|
(17,834 |
) |
|
— |
|
||
Net loss | $ |
(23,870,546 |
) |
$ |
(12,850,301 |
) |
||
Less deemed dividend of beneficial conversion feature |
|
— |
|
|
(825,366 |
) |
||
Less deemed dividend on warrant discount |
|
— |
|
|
(825,366 |
) |
||
Net loss attributable to |
$ |
(23,870,546 |
) |
$ |
(14,501,033 |
) |
||
Net loss per share attributable to |
||||||||
Basic | $ |
(2.66 |
) |
$ |
(2.61 |
) |
||
Diluted | $ |
(2.66 |
) |
$ |
(2.61 |
) |
||
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, basic and diluted |
|
8,983,294 |
|
|
5,546,078 |
|
STATEMENTS OF CASH FLOWS | ||||||||
For the Years Ended
|
||||||||
2021 |
|
2020 |
||||||
Cash flows used in operating activities | ||||||||
Net loss | $ |
(23,870,546 |
) |
$ |
(12,850,301 |
) |
||
Adjustments to reconcile net loss to net cash from operating activities: | ||||||||
Depreciation |
|
596,505 |
|
|
474,621 |
|
||
Amortization |
|
385,093 |
|
|
10,152 |
|
||
Gain on disposal of equipment |
|
(6,400 |
) |
|
— |
|
||
Stock-based compensation |
|
4,040,207 |
|
|
2,318,502 |
|
||
Reserve for prepaid assets |
|
179,000 |
|
|
— |
|
||
Restricted stock awards |
|
— |
|
|
62,431 |
|
||
Noncash conversion of note payable to grant income |
|
(51,000 |
) |
|
— |
|
||
Impairment on property, plant, and equipment |
|
8,317 |
|
|
239,734 |
|
||
Deferred taxes |
|
7,534 |
|
|
— |
|
||
Gain on sale of investment securities available-for-sale |
|
— |
|
|
13,927 |
|
||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable |
|
(382,970 |
) |
|
(454,853 |
) |
||
Inventory |
|
(3,199,439 |
) |
|
(3,859,932 |
) |
||
Prepaid expenses and other current assets |
|
(922,058 |
) |
|
(2,256,511 |
) |
||
Deferred rent |
|
368,894 |
|
|
360,786 |
|
||
Deposits |
|
(86,920 |
) |
|
30,954 |
|
||
Accounts payable |
|
(474,519 |
) |
|
591,213 |
|
||
Payroll liabilities |
|
82,059 |
|
|
231,824 |
|
||
Accrued expenses |
|
1,230,436 |
|
|
403,481 |
|
||
Net cash from operating activities |
|
(22,095,807 |
) |
|
(14,683,972 |
) |
||
Cash flows used in investing activities | ||||||||
Purchase of property, plant, and equipment |
|
(1,555,191 |
) |
|
(1,059,858 |
) |
||
Proceeds on sale of property, plant, and equipment |
|
12,700 |
|
|
— |
|
||
Deposits on equipment to be acquired |
|
(489,325 |
) |
|
— |
|
||
Purchase of software |
|
(156,855 |
) |
|
— |
|
||
Acquisition of a business, net of cash acquired |
|
(10,449,587 |
) |
|
— |
|
||
Purchase of investment securities available-for-sale |
|
(1,028 |
) |
|
(8,171,129 |
) |
||
Proceeds from maturities of investment securities available-for-sale |
|
— |
|
|
4,950,000 |
|
||
Net cash from investing activities |
|
(12,639,286 |
) |
|
(4,280,987 |
) |
||
Cash flows from financing activities | ||||||||
Issuance of common stock |
|
66,744 |
|
|
66,110,517 |
|
||
Issuance of preferred stock |
|
— |
|
|
10,000,006 |
|
||
Common stock issuance costs |
|
(82,043 |
) |
|
(1,268,772 |
) |
||
Preferred stock issuance costs |
|
— |
|
|
(147,721 |
) |
||
Capital contribution |
|
— |
|
|
298,103 |
|
||
Restricted stock units issued |
|
48 |
|
|
— |
|
||
Withholding tax payments for share based compensation |
|
(219,158 |
) |
|
— |
|
||
Repurchased common stock |
|
— |
|
|
(20,532 |
) |
||
Stock options exercised |
|
810,656 |
|
|
197,329 |
|
||
Net cash from financing activities |
|
576,247 |
|
|
75,168,930 |
|
||
Net change in cash and cash equivalents |
|
(34,158,846 |
) |
|
56,203,971 |
|
||
Cash and cash equivalents beginning of year |
|
57,208,080 |
|
|
1,004,109 |
|
||
Cash and cash equivalents end of year | $ |
23,049,234 |
|
$ |
57,208,080 |
|
||
Supplemental disclosures of non-cash information | ||||||||
Noncash conversion of note payable to grant income | $ |
51,000 |
|
$ |
— |
|
||
Unrealized gain (loss) on available-for-sale securities | $ |
(75,223 |
) |
$ |
14,433 |
|
||
Common stock issued in connection with the acquisition of a business | $ |
1,834,857 |
|
$ |
— |
|
||
Conversion of preferred stock to common stock | $ |
— |
|
$ |
16,575,236 |
|
||
Purchases of equipment included in deposits at the beginning of the year | $ |
— |
|
$ |
14,699 |
|
||
Purchases of equipment included in accrued expenses | $ |
26,141 |
|
$ |
— |
|
BALANCE SHEETS | ||||||||
As of | ||||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ |
23,049,234 |
|
$ |
57,208,080 |
|
||
Accounts receivable, net |
|
1,268,718 |
|
|
839,659 |
|
||
Investment securities available-for-sale |
|
8,635,077 |
|
|
8,706,844 |
|
||
Inventory |
|
10,221,343 |
|
|
6,295,898 |
|
||
Prepaid expenses and other current assets, net |
|
3,827,543 |
|
|
2,847,319 |
|
||
Deposits |
|
679,919 |
|
|
97,674 |
|
||
Total current assets |
|
47,681,834 |
|
|
75,995,474 |
|
||
Noncurrent assets | ||||||||
Property and equipment, net |
|
4,512,935 |
|
|
3,513,488 |
|
||
Intangible assets, net |
|
4,838,854 |
|
|
137,092 |
|
||
|
6,486,000 |
|
|
— |
|
|||
Deferred rent |
|
2,327,752 |
|
|
2,696,646 |
|
||
Total noncurrent assets |
|
18,165,541 |
|
|
6,347,226 |
|
||
Total assets | $ |
65,847,375 |
|
$ |
82,342,700 |
|
||
Liabilities and Stockholders’ Equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ |
888,768 |
|
$ |
1,315,964 |
|
||
Payroll liabilities |
|
814,163 |
|
|
722,915 |
|
||
Accrued expenses |
|
2,083,090 |
|
|
704,543 |
|
||
Total current liabilities |
|
3,786,021 |
|
|
2,743,422 |
|
||
Long-term liabilities | ||||||||
Deferred tax liability, net |
|
7,534 |
|
|
— |
|
||
Note payable |
|
— |
|
|
51,000 |
|
||
Total long-term liabilities |
|
7,534 |
|
|
51,000 |
|
||
Total liabilities |
|
3,793,555 |
|
|
2,794,422 |
|
||
Stockholders’ equity | ||||||||
Common stock, |
|
9,095 |
|
|
8,893 |
|
||
Additional paid-in capital |
|
117,903,455 |
|
|
111,452,346 |
|
||
Accumulated other comprehensive income (loss) |
|
(61,016 |
) |
|
14,207 |
|
||
Accumulated deficit |
|
(55,797,714 |
) |
|
(31,927,168 |
) |
||
Total stockholders’ equity |
|
62,053,820 |
|
|
79,548,278 |
|
||
Total liabilities and stockholders’ equity | $ |
65,847,375 |
|
$ |
82,342,700 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220308005920/en/
ICR
646-277-1260
Reed.Anderson@icrinc.com
Source:
FAQ
What were Laird Superfood's earnings in FY2021?
What is Laird Superfood's outlook for 2022?
What was Laird Superfood's net loss for Q4 2021?
How did online sales perform for Laird Superfood in FY2021?